Metis TechBio revenue and financials

7666 · HKEX · HKD

$8.47Change from previous close: +1.26%Absolute change: +$0.11

Close · November 16, 2026

In the fiscal year ended December 2025, Metis TechBio reported revenue of ¥105M (+6,985.02% year over year). The net loss was ¥391.84M.

Annual revenue · 2025: ¥105M
  1. ¥554K2022
  2. ¥9.34M2023
  3. ¥1.48M2024
  4. ¥105M2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+6,985.02%
2025 vs 2024
Net margin
-373.2%
2024: -33,684.1%

How Metis TechBio is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of CNY; per-share values in CNY; shares in millions.

Income statement · Annual
Item2025202420232022
Total revenue1051.59.30.6
Cost of revenue1.90.73.80.2
Gross profit1030.85.60.3
Selling, general and administrative224111112136
Research and development270274290249
Operating income-374-371-393-377
EBIT-374-371-393-377
EBITDA-345-338-364-371
Interest expense31.816870.21.9
Pre-tax income-392-499-582-513
Income tax0.10.00.00.0
Net income-392-499-582-513
Net income to common shareholders-392-499-582-513
Basic EPS-0.47-0.64-0.72-0.48
Diluted EPS-0.47-0.64-0.72-0.48
Average shares (basic)8417848061,064
Average shares (diluted)8417848061,064

Companies in the group: same industry, similar size